Drug Discovery

GSK forms strategic partnership with Alector to produce monoclonal antibodies for neurodegenerative diseases.

The lack of female representation in clinical trials impairs the very foundation that the development of safe and effective medicines is built upon.

Care must be taken to ensure patients understand the difference between gene therapy and the different kinds of gene editing.

What was described by a University of California professor as gene therapy's "single most remarkable achievement?"

AI opens up new opportunities in R&D – and also provides pharma companies with new ways to connect with patients for better outcomes.

How can we prevent the retinal degradation caused by geographic atrophy?

What does the future hold for Tregs? Treg-cell therapy could transform the way we treat autoimmune disease and transplant rejection.

We look back on key interviews and opinions from individuals featured on our 2021 Power List.

We reveal The Medicine Maker 2021 Power List!

Why organ-on-chip technology could transform drug discovery and development.